MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Neuromodulatory role of subthalamic nucleus deep brain stimulation in Parkinson’s disease patients

S. Szlufik, A. Przybyszewski, K. Duszynska-Was, I. Laskowska-Levy, J. Dutkiewicz, A. Drzewinska, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Neuropathology of a South Korean with Perry syndrome with DCTN1 T78C mutation

S. Kim, E. Chung, J. Baik (Busan, Republic of Korea)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG
1:45pm-3:15pm
Neuroprotective Effects of A Combination of Curcumin and Mucuna Prurience in Rotenone Induced Mice Model of Parkinson’s Disease

M. Panchwadkar, P. Rane, D. Khatri, V. Undale (Pune, India)

Neuropharmacology  ·  Hall 3FG
1:45pm-3:15pm
Neuroprotective effects of coffee ingredients against rotenone-induced neurodegeneration in parkinsonian model

I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, Y. Kitamura, M. Asanuma (Okayama, Japan)

Neuropharmacology  ·  Hall 3FG
1:45pm-3:15pm
Neuroprotective role of Tinospora cordifolia in MPTP induced Parkinsonian mouse model

S. Singh, H. Birla, S. Rai, W. Zahra, S. Singh (Varanasi, India)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Neurorestorative effects of glycine transporter 1-inhibitor and D-Serine in a mouse model of nigrostriatal dopaminergic degeneration

V. Francardo, Y. Schmitz, D. Sulzer, M.A. Cenci (Lund, Sweden)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
New Nomenclature Of Genetic Myoclonus Syndromes

S. Veen, R. Zutt, C. Klein, C. Marras, S. Berkovic, J. Caviness, H. Shibasaki, T. De Koning, M. Tijssen (Groningen, Netherlands)

Myoclonus  ·  Hall 3FG
1:45pm-3:15pm
Nigral stimulation for the treatment of refractory gait disturbances in Parkinson’s disease

M. Carmona-Abellán, D. Moreno, M. Alegre, J. Guridi, R. Luquin (Pamplona, Spain)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
No deleterious effect of unilateral Gamma Knife thalamotomy on gait and posture in patients with essential tremor

T. Witjas, E. Boutin, A. Eusebio, R. Carron, J. Régis, JP. Azulay, M. Vaugoyeau (Marseille, France)

Surgical Therapy: Other Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Non-motor symptoms and alteration of brain networks in patients with blepharospasm and hemifacial spasm

YJ. Guo, CM. Chen, MH. Chang (Taichung, Taiwan)

Neuroimaging (Non-PD)  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 59
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley